A phase II study of continuous dosing sunitinib in patients with non-GIST soft tissue sarcoma: early results [abstract]
A phase II study of continuous dosing sunitinib in patients with non-GIST soft tissue sarcoma: early results [abstract]. Connective Tissue Oncology Society. 2007; 881.